TAUNS Laboratories, Inc.
197A.T · JPX
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Revenue | ¥18,627,990 | ¥18,434,863 | ¥15,673,099 | ¥17,456,987 |
| % Growth | 1% | 17.6% | -10.2% | – |
| Cost of Goods Sold | ¥6,302,198 | ¥5,936,530 | ¥6,886,650 | ¥3,169,547 |
| Gross Profit | ¥12,325,792 | ¥12,498,333 | ¥8,786,449 | ¥14,287,440 |
| % Margin | 66.2% | 67.8% | 56.1% | 81.8% |
| R&D Expenses | ¥1,132,023 | ¥0 | ¥723,371 | ¥776,309 |
| G&A Expenses | ¥17,791 | ¥27,991 | ¥27,991 | ¥1,812,024 |
| SG&A Expenses | ¥4,060,766 | ¥3,043,729 | ¥3,819,170 | ¥2,321,574 |
| Sales & Mktg Exp. | ¥4,042,972 | ¥3,015,738 | ¥3,791,179 | ¥252,636 |
| Other Operating Expenses | -¥1,132,023 | ¥1,424,510 | -¥723,368 | ¥0 |
| Operating Expenses | ¥4,060,766 | ¥4,468,239 | ¥3,819,173 | ¥3,097,883 |
| Operating Income | ¥8,265,026 | ¥8,030,094 | ¥4,967,276 | ¥11,189,557 |
| % Margin | 44.4% | 43.6% | 31.7% | 64.1% |
| Other Income/Exp. Net | -¥63,151 | -¥195,403 | -¥312,419 | -¥3,213,880 |
| Pre-Tax Income | ¥8,201,875 | ¥7,834,691 | ¥4,654,856 | ¥7,975,677 |
| Tax Expense | ¥1,886,468 | ¥2,060,605 | ¥1,619,993 | ¥3,494,924 |
| Net Income | ¥6,315,407 | ¥5,774,086 | ¥3,034,863 | ¥4,480,753 |
| % Margin | 33.9% | 31.3% | 19.4% | 25.7% |
| EPS | 62.07 | 57.74 | 30.35 | 44.81 |
| % Growth | 7.5% | 90.2% | -32.3% | – |
| EPS Diluted | 58.9 | 57.74 | 30.35 | 44.81 |
| Weighted Avg Shares Out | 101,741 | 106,947 | 100,000 | 100,000 |
| Weighted Avg Shares Out Dil | 107,223 | 100,000 | 100,000 | 100,000 |
| Supplemental Information | – | – | – | – |
| Interest Income | ¥7,038 | ¥2,342 | ¥3,967 | ¥35 |
| Interest Expense | ¥102,904 | ¥31,211 | ¥21,809 | ¥8,378 |
| Depreciation & Amortization | ¥715,426 | ¥676,163 | ¥639,973 | ¥567,237 |
| EBITDA | ¥9,020,205 | ¥8,646,446 | ¥5,316,638 | ¥8,551,292 |
| % Margin | 48.4% | 46.9% | 33.9% | 49% |